Scarica l'app Stockscreener
1.89
3.08%
-0.06
Dopo l'orario di chiusura:
1.92
0.03
+1.59%
Precedente Chiudi:
$1.95
Aprire:
$2
Volume 24 ore:
259.38K
Relative Volume:
0.74
Capitalizzazione di mercato:
$46.70M
Reddito:
-
Utile/perdita netta:
$-16.51M
Rapporto P/E:
-1.3971
EPS:
-1.3528
Flusso di cassa netto:
$-15.68M
1 W Prestazione:
-7.80%
1M Prestazione:
-20.92%
6M Prestazione:
-32.26%
1 anno Prestazione:
-31.27%
Intervallo 1D:
$1.87
$2.00
Intervallo di 1 settimana:
$1.87
$2.25
Portata 52W:
$1.675
$8.94
Medicus Pharma Ltd Stock (MDCX) Company Profile
Nome
Medicus Pharma Ltd
Settore
Industria
Telefono
610-540-7515
Indirizzo
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
Confronta MDCX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDCX
Medicus Pharma Ltd
|
1.89 | 48.18M | 0 | -16.51M | -15.68M | -1.3528 |
|
LLY
Lilly Eli Co
|
1,027.51 | 903.41B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
211.58 | 505.98B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
223.32 | 395.86B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
132.57 | 253.97B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
100.30 | 245.75B | 63.90B | 19.05B | 13.05B | 7.5596 |
Medicus Pharma Ltd Borsa (MDCX) Ultime notizie
Medicus Pharma Ltd. Receives Full United Kingdom Regulatory and Ethical Approvals To Expand Phase 2 Clinical Study (SKNJCT-003) To Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin - Greenville Online
Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement - Norwich Bulletin
Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025 - Victorville Daily Press
Medicus Pharma’s Warrant Inducement Agreement Announced - TipRanks
Medicus Pharma Elevates President Carolyn Bonner to CFO as Clinical Pipeline Accelerates - MyChesCo
Medicus Pharma Ltd. To Present at Brookline Capital Markets - Daytona Beach News-Journal
Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE - Daytona Beach News-Journal
Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin - The Asheville Citizen Times
Medicus Pharma Ltd. Announces $8.0 Million Non-Dilutive Debenture Financing - The Times Telegram
Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject - Daytona Beach News-Journal
Medicus Pharma secures $5.1 million from warrant exercise agreement By Investing.com - Investing.com Nigeria
Medicus Pharma secures $5.1 million from warrant exercise agreement - Investing.com India
Medicus Pharma Shakes Up Executive Ranks as President Takes on CFO Role - MSN
How Medicus Pharma Ltd. stock reacts to oil prices2025 Breakouts & Breakdowns & Smart Allocation Stock Tips - Newser
How Medicus Pharma Ltd. Equity Warrant stock trades during market volatilityJuly 2025 PostEarnings & Consistent Profit Focused Trading Strategies - Newser
Is Medicus Pharma Ltd. Equity Warrant stock attractive for retirement portfoliosTrade Risk Report & Free Long-Term Investment Growth Plans - Newser
Medicus Pharma appoints Carolyn Bonner as CFO - Pharmafile
How currency fluctuations impact Medicus Pharma Ltd. stockJuly 2025 Institutional & Momentum Based Trading Ideas - Newser
Medicus Pharma Ltd. Strengthens Leadership and Expands Clinical Trials - MSN
Medicus Pharma promotes president to chief financial officer - Pennsylvania Business Report -
Should I buy Medicus Pharma Ltd. (N460) stock before earnings seasonWeekly Risk Summary & Scalable Portfolio Growth Methods - Newser
Disrupting a $6 Billion Skin Cancer Market: The Small-Cap Biotech (MDCX) Advancing a Non-Surgical Patch - marketscreener.com
How Medicus Pharma Ltd. (N460) stock gains from tech spendingJuly 2025 Setups & Safe Capital Allocation Plans - Newser
How big funds are accumulating Medicus Pharma Ltd. (N460) stockInsider Buying & Technical Confirmation Trade Alerts - Newser
Is Medicus Pharma Ltd. (N460) stock a fit for income portfoliosJuly 2025 Pullbacks & Expert Verified Movement Alerts - Newser
Medicus Pharma shares updates on basal cell carcinoma trials - Pharmafile
Medicus Pharma appoints Carolyn Bonner as CFO after Quinlan resigns By Investing.com - Investing.com Canada
Medicus Pharma appoints Bonner as president and CFO following Quinlan’s resignation - Investing.com Australia
Medicus Pharma applies for FDA priority voucher to accelerate SkinJect’s non-invasive BCC therapy - Proactive financial news
Medicus Pharma appoints Carolyn Bonner as president and CFO By Investing.com - Investing.com Nigeria
Medicus Pharma names president Carolyn Bonner as new CFO - Proactive financial news
Medicus Pharma Ltd Azioni (MDCX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.37%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):